• Events
  • Media center
  • Careers
  • Contact
  • Support us
EORTC
  • Activities
    • Clinical trials
    • Other research initiatives
    • Data sharing
    • Quality assurance
    • Education & training
    • Early career
    • Public policy
  • Research fields
    • Tumours
    • Cross-discipline
  • Network & partners
    • Members
    • Partners
    • Government bodies
    • Liaison offices
  • Research tools
    • Tools
    • Clinical trials database
    • Bibliography
    • Policies
    • Guidelines
    • Request for data
  • About us
    • Our mission
    • Strategic overview
    • Funding
    • History
    • Governance
    • Headquarters
News : Dr. Emad Shash discusses organizational and regulatory constraints for international clinical trials for rare cancers
Gender plays a role in progression-free and disease-specific survival according to five EORTC studies in stage III-IV melanoma patients
Back to news list
Radiotherapy remains the treatment of first choice for high-risk low-grade glioma: results of EORTC trial 22033-26033 at ASCO 2013
News Uncategorized
Share
  • Linkedin
  • Twitter
  • Facebook

Dr. Emad Shash discusses organizational and regulatory constraints for international clinical trials for rare cancers

23 May 2013

In an article appearing in ecancermedicalscience, the EORTC’s Emad Shash, Anastassia Negrouk, Sandrine Marreaud, Vassilis Golfinopoulos, Denis Lacombe and Francoise Meunier outline organizational and regulatory constraints for international clinical trials for rare cancers. In an accompanying interview, Dr. Shash offers further insight into this topic.

Gender plays a role in progression-free and disease-specific survival according to five EORTC studies in stage III-IV melanoma patients
Back to news list
Radiotherapy remains the treatment of first choice for high-risk low-grade glioma: results of EORTC trial 22033-26033 at ASCO 2013

Related News

Does radiofrequency ablation of unresectable colorectal liver metastases prolong long-term survival?

23 Mar 2017

Could an early PET scan help better manage Hodgkin Lymphoma?

17 Mar 2017

EORTC introduces new quality of life module to measure cancer-related fatigue

7 Mar 2017

In memory of Professor Franck Bonnetain

6 Jun 2017

Does radiofrequency ablation of unresectable colorectal liver metastases prolong long-term survival?

23 Mar 2017

Could an early PET scan help better manage Hodgkin Lymphoma?

17 Mar 2017
  • Activities
    • Clinical trials
    • Other research initiatives
    • Data sharing
    • Quality assurance
    • Education & training
    • Early career
    • Public policy
  • Research fields
    • Tumours
    • Cross-discipline
  • Network & partners
    • Members
    • Partners
    • Government bodies
    • Liaison offices
  • Research tools
    • Tools
    • Clinical trials database
    • Bibliography
    • Policies
    • Guidelines
    • Request for data
  • About us
    • Our mission
    • Strategic overview
    • Funding
    • History
    • Governance
    • Headquarters
Subscribe to our newsletter Member area Eur. J. Cancer
Follow us on
  • Linkedin
  • Twitter
  • Facebook
  • Youtube
  • © EORTC
  • Legal notice
  • Cookies
  • link